{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:45:59Z","timestamp":1785743159877,"version":"3.56.0"},"reference-count":25,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Amyloidosis encompasses a group of diseases characterised by extracellular deposition of misfolded protein fibrils, potentially leading to organ dysfunction. Liver involvement occurs via direct amyloid infiltration, common in immunoglobulin light chain (\n                      <jats:styled-content style=\"fixed-case\">AL<\/jats:styled-content>\n                      ) amyloidosis, or congestive hepatopathy, more typical in transthyretin (\n                      <jats:styled-content style=\"fixed-case\">ATTR<\/jats:styled-content>\n                      ) amyloidosis. The utility of liver stiffness measurement (\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      ) using FibroScan as a non\u2010invasive alternative to liver biopsy remains uncertain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To prospectively evaluate the utility of Fibroscan in diagnosing and monitoring for hpeatic infiltratioin in AL and ATTR amyloidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This pilot prospective study included 14 patients with newly diagnosed amyloidosis at a single centre. Liver involvement was evaluated via FibroScan, liver function tests, liver ultrasound and cardiac biomarkers at baseline and follow\u2010up over 24 months.\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      trends were then descriptively analysed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five patients (35.7%) \u2013 three\n                      <jats:styled-content style=\"fixed-case\">ATTR<\/jats:styled-content>\n                      and two\n                      <jats:styled-content style=\"fixed-case\">AL<\/jats:styled-content>\n                      amyloidosis \u2013 had baseline\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      &gt;10 kPa, suggestive of increased liver stiffness.\n                      <jats:styled-content style=\"fixed-case\">AL<\/jats:styled-content>\n                      amyloidosis patients exhibited higher\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      values (&gt;17.3\n                      <jats:styled-content style=\"fixed-case\">kPa<\/jats:styled-content>\n                      ) despite normal\n                      <jats:styled-content style=\"fixed-case\">ALP<\/jats:styled-content>\n                      levels.\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      improved in 60% of treated patients. No observable association was found between\n                      <jats:styled-content style=\"fixed-case\">ALP<\/jats:styled-content>\n                      levels and\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      trends. In\n                      <jats:styled-content style=\"fixed-case\">ATTR<\/jats:styled-content>\n                      amyloidosis patients,\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      &gt;10\n                      <jats:styled-content style=\"fixed-case\">kPa<\/jats:styled-content>\n                      was associated with advanced Gilmore stage and elevated\n                      <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">proBNP<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This pilot study suggests\n                      <jats:styled-content style=\"fixed-case\">LSM<\/jats:styled-content>\n                      may provide a useful early non\u2010invasive adjunct in the assessment of hepatic involvement in amyloidosis; however, it should be interpreted as a non\u2010specific marker. Larger studies are required to validate the diagnostic and prognostic role of FibroScan in this population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/imj.70570","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:07:02Z","timestamp":1785740822000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single\u2010centre prospective pilot study"],"prefix":"10.1111","author":[{"given":"M","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Vootukuru","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tjahyadi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Clayton","family":"Chubb","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"},{"name":"School of Translational Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jina","sequence":"additional","affiliation":[{"name":"Department of Haematology Eastern Health  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-8326","authenticated-orcid":false,"given":"SB","family":"Ting","sequence":"additional","affiliation":[{"name":"Department of Haematology Eastern Health  Victoria Australia"},{"name":"Eastern Clinical School Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bloom","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"},{"name":"Eastern Clinical School Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sawhney","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"},{"name":"Eastern Clinical School Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Department of Haematology Eastern Health  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-8713","authenticated-orcid":false,"given":"O.","family":"Niewiadomski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Eastern Health  Melbourne Victoria Australia"},{"name":"Eastern Clinical School Monash University  Melbourne Victoria Australia"},{"name":"University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys MB","year":"2006","journal-title":"Annu Rev Med"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park MA","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMc1917321","article-title":"Epidemiologic and survival trends in amyloidosis, 1987\u20102019","volume":"382","author":"Ravichandran S","year":"2020","journal-title":"N Engl J Med"},{"key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/radiographics.13.6.8290725","article-title":"CT evaluation of amyloidosis: spectrum of disease","volume":"13","author":"Urban BA","year":"1993","journal-title":"Radiographics"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.510250122","article-title":"Hepatic amyloidosis: clinical appraisal in 77 patients","volume":"25","author":"Gertz MA","year":"1997","journal-title":"Hepatology"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051440","article-title":"Cardio\u2010hepatic interaction in cardiac amyloidosis","volume":"13","author":"Ihne\u2010Schubert SM","year":"2024","journal-title":"J Clin Med"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed SF","year":"2014","journal-title":"JACC Heart Fail"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.prp.2012.07.011","article-title":"Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis","volume":"208","author":"Sarsik B","year":"2012","journal-title":"Pathol Res Pract"},{"key":"e_1_2_11_10_1","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle RA","year":"1995","journal-title":"Semin Hematol"},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, Tours, France, 18\u201022 April 2004","volume":"79","author":"Gertz MA","year":"2005","journal-title":"Am J Hematol"},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar AD","year":"2016","journal-title":"Lancet"},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1053\/j.ajkd.2006.03.036","article-title":"Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy","volume":"47","author":"Sucker C","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2009.11.018","article-title":"Liver stiffness is directly influenced by central venous pressure","volume":"52","author":"Millonig G","year":"2010","journal-title":"J Hepatol"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2022-eular.3993","article-title":"Transient elastography (Fibroscan); as a new non\u2010invasive diagnostic method for detecting hepatic involvement of amyloidosis","volume":"81","author":"Bektas M","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_11_16_1","first-page":"653","article-title":"Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosis","volume":"104","author":"Brunger AF","year":"2024","journal-title":"Ann Hematol"},{"key":"e_1_2_11_17_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132485","article-title":"Prevalence, clinical significance and prognosis value of liver stiffness measurement anomalies in transthyretin cardiac amyloidosis","volume":"416","author":"Lointier E","year":"2024","journal-title":"Int J Cardiol"},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/13506129.2010.543443","article-title":"Non\u2010invasive detection of hepatic amyloidosis: FibroScan, a new tool","volume":"18","author":"Loustaud\u2010Ratti VR","year":"2011","journal-title":"Amyloid"},{"key":"e_1_2_11_19_1","first-page":"49","article-title":"Liver stiffness: a novel parameter for the diagnosis of liver disease","volume":"2","author":"Mueller S","year":"2010","journal-title":"Hepat Med"},{"key":"e_1_2_11_20_1","first-page":"605","article-title":"Fibroscan (transient elastography) for the measurement of liver fibrosis","volume":"8","author":"Afdhal NH","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.dld.2022.10.009","article-title":"Non\u2010invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII \u2010 an update","volume":"55","author":"Segna D","year":"2023","journal-title":"Dig Liver Dis"},{"key":"e_1_2_11_22_1","first-page":"349","article-title":"Amyloid disease of the liver. Correlation of clinical, functional and morphologic features in forty\u2010seven patients","volume":"33","author":"Levine RA","year":"1962","journal-title":"Am J Med"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.022","article-title":"Light chain amyloidosis","volume":"10","author":"Milani P","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1148\/radiol.10100013","article-title":"Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography","volume":"257","author":"Colli A","year":"2010","journal-title":"Radiology"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0735-1097(98)00045-X","article-title":"Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis","volume":"31","author":"Takemura G","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore JD","year":"2018","journal-title":"Eur Heart J"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70570","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.70570","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:07:06Z","timestamp":1785740826000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.70570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":25,"alternative-id":["10.1111\/imj.70570"],"URL":"https:\/\/doi.org\/10.1111\/imj.70570","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"2025-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"imj.70570"}}